FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

JE Harrison

Research Profile

Chemicals & Drugs

Disorders

Asthma

Procedures

Concepts & Ideas

Phenomena

Co-author Network

Publications

TOP 3
Robert A Nathan; Anjuli S Nayak; DF Graft; M Lawrence; F J Picone; Tahir Ahmed; J Wolfe; M L Vanderwalker; KB Nolop; JE Harrison
Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.
J E Fish; Jill Karpel; T J Craig; G W Bensch; Michael Noonan; D R Webb; B Silverman; Eric J Schenkel; AR Rooklin; Joe Ramsdell; R Nathan; J G Leflein; Jay Grossman; DF Graft; R G Gower; S M Garay; E Frigas; A C Degraff; Edwin A Bronsky; David I Bernstein; W Berger; L Shneyer; KB Nolop; JE Harrison
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
JP Kemp; Robert B Berkowitz; S D Miller; John Joseph Murray; KB Nolop; JE Harrison
Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of JE Harrison (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Robert A Nathan; Anjuli S Nayak; DF Graft; M Lawrence; F J Picone; Tahir Ahmed; J Wolfe; M L Vanderwalker; KB Nolop; JE Harrison
Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2001;86(2):203-10.
2000: J E Fish; Jill Karpel; T J Craig; G W Bensch; Michael Noonan; D R Webb; B Silverman; Eric J Schenkel; AR Rooklin; Joe Ramsdell; R Nathan; J G Leflein; Jay Grossman; DF Graft; R G Gower; S M Garay; E Frigas; A C Degraff; Edwin A Bronsky; David I Bernstein; W Berger; L Shneyer; KB Nolop; JE Harrison
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
The Journal of allergy and clinical immunology 2000;106(5):852-60.
2000: JP Kemp; Robert B Berkowitz; S D Miller; John Joseph Murray; KB Nolop; JE Harrison
Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.
The Journal of allergy and clinical immunology 2000;106(3):485-92.
2000: Anjuli S Nayak; C Banov; Jonathan Corren; B K Feinstein; A Floreani; B F Friedman; A Goldsobel; G M Gottschlich; P J Hannaway; KATHY LAMPL; R J Lapidus; M Lawrence; William Lumry; Z Munk; David S Pearlman; Anthony Scardella; Eric J Schenkel; AT Segal; N Segall; B Silverman; L Shneyer; KB Nolop; JE Harrison
Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2000;84(4):417-24.
1999: David I Bernstein; Robert B Berkowitz; Paul Chervinsky; D J Dvorin; Albert F Finn; G N Gross; M Karetzky; JP Kemp; Craig LaForce; William Lumry; Louis Mendelson; H Nelson; David S Pearlman; Gary Rachelefsky; Paul H Ratner; L Repsher; AT Segal; J C Selner; GA Settipane; AA Wanderer; FM Cuss; KB Nolop; JE Harrison
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
Respiratory medicine 1999;93(9):603-12.
1998: Harold B Kaiser; C H Banov; R R Berkowitz; David I Bernstein; Edwin A Bronsky; JW Georgitis; Louis Mendelson; AR Rooklin; L J Sholler; W W Stricker; JE Harrison; Melvyn R Danzig; Richard R Lorber
Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.
American journal of therapeutics 1998;5(4):245-51.